A Method for Interdicting the Development of Severe Jaundice in Newborns by Inhibiting the Production of Bilirubin

Pediatrics

Volumn 113, Issue 1 I, 2004, Pages 135-

  Alexander, Duane ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; MESOPORPHYRIN TIN;

BILIRUBIN METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ENZYME INHIBITION; HUMAN; INFANT; JAUNDICE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; NEWBORN JAUNDICE; NOTE; PHOTOTHERAPY; PRIORITY JOURNAL; SIDE EFFECT;

BILIRUBIN; DRUG APPROVAL; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; METALLOPORPHYRINS; RANDOMIZED CONTROLLED TRIALS;

EID: 0346726158     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.1.135     Document Type: Note

References (4)

1. Kappas A. A method for interdicting the development of severe jaundice in newborns by inhibiting the production of bilirubin. Pediatrics. 2004;113:119-123
2. Valaes T, Petmezaki S, Henschke C, Drummond GS, Kappas A. Control of jaundice in preterm newborns by an inhibitor of bilirubin production: studies with tin-mesoporphyrin. Pediatrics. 1994;93:1-11
3. Valaes T, Drummond GS, Kappas A. Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 1998;101(5). Available at: http://www.pediatrics.org/cgi/content/full/101/5/e1
4. Martinez JC, Garcia HO, Otheguy L, Drummond GS, Kappas A. Control of severe hyperbilirubinemia in full-term newborns with the inhibitor of bilirubin production Sn-mesoporphyrin. Pediatrics. 1999;103:1-5